Research Analysts’ Weekly Ratings Changes for Oscar Health (OSCR) (2024)

Several brokerages have updated their recommendations and price targets on shares of Oscar Health (NYSE: OSCR) in the last few weeks:

• 6/12/2024 – Oscar Health had its price target raised by analysts at Wells Fargo & Company from $24.00 to $27.00. They now have an “overweight” rating on the stock.
• 5/30/2024 – Oscar Health was upgraded by analysts at Baird R W to a “strong-buy” rating.
• 5/30/2024 – Oscar Health is now covered by analysts at Robert W. Baird. They set an “outperform” rating and a $28.00 price target on the stock.
• 5/30/2024 – Oscar Health had its “neutral” rating reaffirmed by analysts at Bank of America Co.. They now have a $21.00 price target on the stock, down previously from $25.00.
• 5/20/2024 – Oscar Health had its price target raised by analysts at Bank of America Co. from $22.00 to $25.00. They now have a “buy” rating on the stock.
• 5/9/2024 – Oscar Health had its price target raised by analysts at Wells Fargo & Company from $20.00 to $24.00. They now have an “overweight” rating on the stock.
• 5/9/2024 – Oscar Health had its price target raised by analysts at The Goldman Sachs Group, Inc. from $16.00 to $21.00. They now have a “neutral” rating on the stock.

Oscar Health Stock Down 1.2 %

Shares of Oscar Health stock opened at $18.78 on Tuesday. The stock has a market capitalization of $4.45 billion, a price-to-earnings ratio of -46.94 and a beta of 1.68. Oscar Health, Inc. has a twelve month low of $4.72 and a twelve month high of $23.44. The company has a current ratio of 1.10, a quick ratio of 1.10 and a debt-to-equity ratio of 0.29. The business’s 50 day simple moving average is $19.01 and its 200-day simple moving average is $14.80.

Oscar Health (NYSE:OSCR – Get Free Report) last posted its earnings results on Tuesday, May 7th. The company reported $0.62 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.28 by $0.34. Oscar Health had a negative return on equity of 5.77% and a negative net margin of 0.82%. The company had revenue of $2.14 billion for the quarter, compared to analysts’ expectations of $1.99 billion. During the same period last year, the business posted ($0.18) earnings per share. The firm’s quarterly revenue was up 45.8% compared to the same quarter last year. Equities research analysts forecast that Oscar Health, Inc. will post -0.05 earnings per share for the current year.

Insider Activity at Oscar Health

In other Oscar Health news, insider Mario Schlosser sold 5,808 shares of the firm’s stock in a transaction that occurred on Monday, June 3rd. The shares were sold at an average price of $19.46, for a total value of $113,023.68. Following the sale, the insider now owns 65,920 shares in the company, valued at $1,282,803.20. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In other Oscar Health news, CAO Victoria Baltrus sold 7,674 shares of the firm’s stock in a transaction dated Monday, June 3rd. The shares were sold at an average price of $19.46, for a total transaction of $149,336.04. Following the transaction, the chief accounting officer now owns 127,754 shares of the company’s stock, valued at approximately $2,486,092.84. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, insider Mario Schlosser sold 5,808 shares of the business’s stock in a transaction dated Monday, June 3rd. The stock was sold at an average price of $19.46, for a total transaction of $113,023.68. Following the sale, the insider now owns 65,920 shares in the company, valued at $1,282,803.20. The disclosure for this sale can be found here. Insiders have sold a total of 81,655 shares of company stock worth $1,589,006 in the last ninety days. 25.11% of the stock is owned by insiders.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in the stock. Avalon Trust Co acquired a new position in shares of Oscar Health during the 1st quarter valued at $69,000. Amalgamated Bank raised its position in Oscar Health by 10.6% in the third quarter. Amalgamated Bank now owns 15,762 shares of the company’s stock worth $88,000 after acquiring an additional 1,516 shares in the last quarter. Prevail Innovative Wealth Advisors LLC acquired a new stake in Oscar Health in the 4th quarter valued at about $92,000. Handelsbanken Fonder AB bought a new position in shares of Oscar Health during the 4th quarter valued at about $110,000. Finally, QRG Capital Management Inc. acquired a new position in shares of Oscar Health in the 3rd quarter worth approximately $117,000. Institutional investors and hedge funds own 75.70% of the company’s stock.

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.

Read More

• Five stocks we like better than Oscar Health
• CD Calculator: Certificate of Deposit Calculator
• Buffett Bails on BYD: What It Means forthe Future of EV Stocks
• Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
• Domino’s vs. Papa John’s: Stock Showdown of Pizza Giants
• Dividend Payout Ratio Calculator
• Williams-Sonoma Makes Stock More Accessible with a Stock Split

Receive News & Ratings for Oscar Health Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oscar Health Inc and related companies with MarketBeat.com's FREE daily email newsletter.